Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


FDA’s Metric System: Quality Scores Are High Priority For Agency, But Industry Concerns Keep Pace Slow

This article was originally published in RPM Report

Executive Summary

FDA is taking the next step towards gathering and reporting manufacturing quality metrics data by releasing a draft guidance outlining an initial list of proposed metrics. However, FDA made clear during an August feedback meeting that it isn’t going to rush the changes through.


Related Content

FDA’s Call for Quality: Revamped GMP Initiative Stresses Cost Savings
FDA Quality Profiling: Agency Hopes to Channel Corporate Attention (And Money) To Quality Systems





Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts